Literature DB >> 21229010

Management of Atrial Fibrillation: Identifying and treating the causes.

S W Rabkin.   

Abstract

Atrial fibrillation is relatively common, particularly among the elderly. Management requires identifying and treating the causes. Treatment aims at improving overall cardiac status. A number of patient factors determine whether treatment should focus on establishing sinus rhythm (electrically or with drugs) and maintaining it or on controlling ventricular rate. For most patients, anticoagulants are recommended to prevent pulmonary thromboembolism.

Entities:  

Year:  1991        PMID: 21229010      PMCID: PMC2145325     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  13 in total

1.  Atrial fibrillation and mortality in an elderly population.

Authors:  F R Lake; K J Cullen; N H de Klerk; M G McCall; D L Rosman
Journal:  Aust N Z J Med       Date:  1989-08

2.  The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation.

Authors:  J E Atwood; J Myers; M Sullivan; S Forbes; S Sandhu; P Callaham; V Froelicher
Journal:  Am Heart J       Date:  1989-11       Impact factor: 4.749

3.  Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease.

Authors:  S W Rabkin; C Tomlinson; B N Corbett; T E Cuddy
Journal:  Can Med Assoc J       Date:  1980-01-12       Impact factor: 8.262

Review 4.  Thromboembolic complications of atrial fibrillation and their prevention: a review.

Authors:  P Petersen
Journal:  Am J Cardiol       Date:  1990-02-02       Impact factor: 2.778

5.  Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors:  P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

6.  The natural history of lone atrial fibrillation. A population-based study over three decades.

Authors:  S L Kopecky; B J Gersh; M D McGoon; J P Whisnant; D R Holmes; D M Ilstrup; R L Frye
Journal:  N Engl J Med       Date:  1987-09-10       Impact factor: 91.245

7.  Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation.

Authors:  M Shenasa; T Kus; M Fromer; R A LeBlanc; M Dubuc; R Nadeau
Journal:  Am J Cardiol       Date:  1988-09-01       Impact factor: 2.778

8.  Clinical approach to paroxysmal atrial fibrillation.

Authors:  P Coumel
Journal:  Clin Cardiol       Date:  1990-03       Impact factor: 2.882

9.  Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs.

Authors:  E M Antman; A D Beamer; C Cantillon; N McGowan; P L Friedman
Journal:  J Am Coll Cardiol       Date:  1990-03-01       Impact factor: 24.094

10.  Asymptomatic cerebral infarction in patients with chronic atrial fibrillation.

Authors:  P A Kempster; R P Gerraty; P C Gates
Journal:  Stroke       Date:  1988-08       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.